Trial Outcomes & Findings for Multicenter, Non-interventional Study, Describing Patients With Inherited Retinal Disease (IRD) in France (NCT NCT05122442)
NCT ID: NCT05122442
Last Updated: 2026-01-27
Results Overview
To describe the genetic testing characteristics To describe the distribution of variant of uncertain significance (VUS - class 3 variants) in IRD-associated genes To describe the proportion of unsolved patients To describe the type of pathogenic variants in each IRD-associated gene identified
COMPLETED
998 participants
12 month
2026-01-27
Participant Flow
Participant milestones
| Measure |
Patients With Inherited Retinal Disease
All patients clinically diagnosed with IRD or with high suspicion for IRDs based on clinical examination and functional tests, regardless of genetic testing
|
|---|---|
|
Overall Study
STARTED
|
998
|
|
Overall Study
COMPLETED
|
998
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Patients With Inherited Retinal Disease
n=982 Participants
All patients clinically diagnosed with IRD or with high suspicion for IRDs based on clinical examination and functional tests, regardless of genetic testing
|
|---|---|
|
Age, Continuous
|
38.92 years
STANDARD_DEVIATION 19.58 • n=982 Participants
|
|
Sex: Female, Male
Female
|
479 Participants
n=982 Participants
|
|
Sex: Female, Male
Male
|
503 Participants
n=982 Participants
|
PRIMARY outcome
Timeframe: 12 monthTo describe the genetic testing characteristics To describe the distribution of variant of uncertain significance (VUS - class 3 variants) in IRD-associated genes To describe the proportion of unsolved patients To describe the type of pathogenic variants in each IRD-associated gene identified
Outcome measures
| Measure |
Patients With Inherited Retinal Disease
n=982 Participants
All patients clinically diagnosed with IRD or with high suspicion for IRDs based on clinical examination and functional tests, regardless of genetic testing
|
|---|---|
|
Proportion of Patients by Type of IRD
Isolated progressive inherited retinal disorders
|
720 Participants
|
|
Proportion of Patients by Type of IRD
Syndromic inherited retinal disorders
|
174 Participants
|
|
Proportion of Patients by Type of IRD
Isolated stationary inherited retinal disorders
|
30 Participants
|
|
Proportion of Patients by Type of IRD
Other
|
58 Participants
|
Adverse Events
Patients With Inherited Retinal Disease
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Hélène DOLLFUS
Hôpitaux Universitaires de Strasbourg (HUS)/ Strasbourg University Hospital
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place